report
AI shows potential in managing idiopathic pulmonary fibrosis: report
AI shows potential in managing idiopathic pulmonary fibrosis: report
It is increasingly being applied to CT scans.
What factors drive the ophthalmology surgical device market?
Eye disorders such as cataracts and glaucoma fuel the sector’s demand.
Global contraceptive drugs and devices market to reach $75b by 2035
Thanks to a rising awareness about family access.
Global flow cytometry market to be valued at $9.85b by 2033
A rise in oncology research has increased the sector’s demand.
Women’s health rehabilitation products market to hit $9.68b by 2034
By application, the “Hospitals” segment is expected to dominate the sector.
7MM Parkinson’s disease market to be valued at $7b by 2033
Eight late-stage pipeline products are expected to launch during the forecast period.
Global liquid biopsy market to hit $7.05b by 2030
Tech advancements like next-generation sequencing drive the sector.
Brachytherapy devices market to reach $534.2m by 2031
By application, the prostate cancer segment dominated in 2024.
Trust in doctors crucial for AI acceptance in Australian healthcare
The majority were comfortable receiving AI information from their doctor.
Emerging markets to see mixed health spending growth
India and Turkiye are experiencing sharp increases in expenditure.
Patient data hub solutions market to be valued at $3.01b by 2033
Thanks to a rising need for centralised data and interoperability.
Blood platelets market to hit $4b by 2030
Thanks to its use in regenerative medicine and biotechnology.
Medical device market on track for mid-single digit growth
The sector is seeing mixed growth across categories.
Diagnostics M&A activity to stay subdued in H2 amidst tariff uncertainty
Deal volume slowed after the first quarter.
Global suppositories market to hit $2.05b by 2030
Its expansion is driven by increasing cases of digestive diseases.
Surgical sutures market to be valued at $6.65b by 2030
Thanks to a rise in surgical interventions driven by an ageing population.
7MM hidradenitis suppurativa market to quadruple by 2034
Thanks to the approval and uptake of next-generation biologics.